Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Melillo

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
The Journal of Clinical Endocrinology and Metabolism|November 4, 2000
Tyrosines 1015 and 1062 are in vivo autophosphorylation sites in ret and ret-derived oncoproteinsD Salvatore, M V Barone, G Salvatore, et al.
Endocrinology|April 1, 1997
Only the substitution of methionine 918 with a threonine and not with other residues activates RET transforming potentialA M Cirafici, G Salvatore, G De Vita, et al.
International Journal of Oncology|March 16, 2000
Glial cell line-derived neutrotrophic factor and neurturin can act as paracrine growth factors stimulating DNA synthesis of Ret-expressing spermatogoniaG Viglietto, S Dolci, P Bruni, et al.
Oncogene|November 13, 2001
RET/PTC1 oncogene signaling in PC Cl 3 thyroid cells requires the small GTP-binding protein RhoM V Barone, L Sepe, R M Melillo, et al.
Experimental Cell Research|October 19, 2000
Pivotal role of the RB family proteins in in vitro thyroid cell transformationR Iuliano, F Trapasso, A Stella, et al.
The Journal of Clinical Endocrinology and Metabolism|October 9, 2004
A new germline RET mutation apparently devoid of transforming activity serendipitously discovered in a patient with atrophic autoimmune thyroiditis and primary ovarian failureG Orgiana, G Pinna, A Camedda, et al.
Cell|February 23, 1990
PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomasM Grieco, M Santoro, M T Berlingieri, et al.
Cancer Research|August 5, 2000
Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survivalG De Vita, R M Melillo, F Carlomagno, et al.
Endocrinology|July 29, 1998
Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's diseaseF Carlomagno, R M Melillo, R Visconti, et al.
Cancer Research|March 10, 1999
Ret-mediated mitogenesis requires Src kinase activityR M Melillo, M V Barone, G Lupoli, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
The Journal of Clinical Endocrinology and Metabolism|November 4, 2000
Tyrosines 1015 and 1062 are in vivo autophosphorylation sites in ret and ret-derived oncoproteinsD Salvatore, M V Barone, G Salvatore, et al.
Endocrinology|April 1, 1997
Only the substitution of methionine 918 with a threonine and not with other residues activates RET transforming potentialA M Cirafici, G Salvatore, G De Vita, et al.
International Journal of Oncology|March 16, 2000
Glial cell line-derived neutrotrophic factor and neurturin can act as paracrine growth factors stimulating DNA synthesis of Ret-expressing spermatogoniaG Viglietto, S Dolci, P Bruni, et al.
Oncogene|November 13, 2001
RET/PTC1 oncogene signaling in PC Cl 3 thyroid cells requires the small GTP-binding protein RhoM V Barone, L Sepe, R M Melillo, et al.
Experimental Cell Research|October 19, 2000
Pivotal role of the RB family proteins in in vitro thyroid cell transformationR Iuliano, F Trapasso, A Stella, et al.
The Journal of Clinical Endocrinology and Metabolism|October 9, 2004
A new germline RET mutation apparently devoid of transforming activity serendipitously discovered in a patient with atrophic autoimmune thyroiditis and primary ovarian failureG Orgiana, G Pinna, A Camedda, et al.
Cell|February 23, 1990
PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomasM Grieco, M Santoro, M T Berlingieri, et al.
Cancer Research|August 5, 2000
Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survivalG De Vita, R M Melillo, F Carlomagno, et al.
Endocrinology|July 29, 1998
Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's diseaseF Carlomagno, R M Melillo, R Visconti, et al.
Cancer Research|March 10, 1999
Ret-mediated mitogenesis requires Src kinase activityR M Melillo, M V Barone, G Lupoli, et al.
Pageof 4